Anaesthesia and critical care department, Hôtel Dieu, 1, place Alexis-Ricordeau 44093 Nantes, university hospital of Nantes, France.
Anaesthesia and critical care department, centre régional hospitalier universitaire, route de Chauvel, Les Abymes, BP 465, 97159, Pointe-à-Pitre cedex, Guadeloupe, France.
Anaesth Crit Care Pain Med. 2019 Jun;38(3):251-257. doi: 10.1016/j.accpm.2018.10.002. Epub 2018 Oct 25.
The evolution of neurological recovery during the first year after aneurysmal Subarachnoid Haemorrhage (SAH) is poorly described.
Patients with SAH in one university hospital from March the 1st 2010, to December 31st 2012, with a one-year follow-up.
Evaluation was performed via phone call at 3, 6 and 12 months. Primary endpoint was poor neurological recovery (modified Rankin Scale 3-4-5-6), one year after SAH. Secondary endpoints were the incidence of lack of self-perceived previous health status recovery and incidence of cognitive disorders, one year after SAH. Risk factors of poor neurological recovery were retrieved with multivariable logistic regression.
Two hundred and eleven patients were included and 208 had a complete follow-up. One hundred and twenty (57.7%) patients were female, 112 (53.8%) had a WFNS grade I-II-III. Seventy (33.6%) patients displayed one-year poor neurological outcome and risk factors of poor outcome were age, baseline Glasgow Coma Score ≤ 8, external ventricular drainage, intra-cranial hypertension and angiographic vasospasm. We observed an improvement in good outcome at 3 months [112 (53.8%) patients], 6 months [127 (61.1%) patients] and one-year [138 (66.3%) patients]. Fifty-nine (35.3%) patients recovered previous health status, 96 (57.5%) had persistent behaviour disorders, and 71 (42.5%) suffered from memory losses at one year.
Neurological recovery seems to improve over time. The same key complications should be targeted worldwide in SAH patients.
Neurological complications in the following of SAH should be actively treated in order to improve outcome. The early neuro-ICU phase remains a key determinant of long-term recovery.
蛛网膜下腔出血(SAH)后第一年的神经恢复演变情况描述不足。
2010 年 3 月 1 日至 2012 年 12 月 31 日期间,在一家大学医院住院的 SAH 患者,随访一年。
通过电话在 3、6 和 12 个月时进行评估。主要终点是 SAH 后一年时神经功能恢复不良(改良 Rankin 量表 3-4-5-6 分)。次要终点是 SAH 后一年时缺乏自我感知的健康状况恢复和认知障碍的发生率。通过多变量逻辑回归检索神经功能恢复不良的危险因素。
共纳入 211 例患者,208 例完成了完整随访。120 例(57.7%)为女性,112 例(53.8%)为 WFNS Ⅰ-Ⅱ-Ⅲ级。70 例(33.6%)患者出现一年时神经功能不良结局,不良结局的危险因素为年龄、基线格拉斯哥昏迷评分≤8、脑室外引流、颅内压增高和血管造影性血管痉挛。我们观察到 3 个月时[112 例(53.8%)患者]、6 个月时[127 例(61.1%)患者]和 1 年时[138 例(66.3%)患者]良好结局的改善。59 例(35.3%)患者恢复了以前的健康状况,96 例(57.5%)患者存在持续性行为障碍,71 例(42.5%)患者在 1 年后出现记忆丧失。
神经功能恢复似乎随时间而改善。SAH 患者应在全球范围内针对这些关键并发症进行治疗。
为了改善预后,应积极治疗蛛网膜下腔出血后的神经并发症。早期神经重症监护病房阶段仍然是长期恢复的关键决定因素。